Vor Biopharma VOR Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's operating lease right-of-use assets in other assets?
- Vor Biopharma (VOR) reported operating lease right-of-use assets in other assets of $2.83M in Q1 2026.
- How has Vor Biopharma's operating lease right-of-use assets in other assets changed year-over-year?
- Vor Biopharma's operating lease right-of-use assets in other assets decreased by 91.6% year-over-year, from $33.7M to $2.83M.
- What is the long-term trend for Vor Biopharma's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Vor Biopharma's operating lease right-of-use assets in other assets has grown at a -29.7% compound annual growth rate (CAGR), from $17.12M to $2.94M.